• Conference
  • Earn CE
  • Free Samples
  • Magazine
  • Subscribe
  • Videos
    • Recent Quotes
    My Watchlist
    Indicators
    Dental Market Index
    Markets
    Stocks
    ETFs
    Tools
    Overview
    News
    Currencies
    International
    Treasuries

    Lemaitre Vascular (NQ: LMAT )

    81.50 +0.91 (+1.13%)
    Streaming Delayed Price Updated: 4:00 PM EDT, Jun 21, 2024 Add to My Watchlist
    Quote
    Overview Detailed Quote Charting Historical Prices
    News
    All News News Headlines Press Releases
    Research
    Quarterly Reports Insider Filings Other Filings

    Price and Volume

    Detailed Quote
    Volume 270,700
    Open 80.67
    Bid (Size) 77.94 (1)
    Ask (Size) 130.22 (2)
    Prev. Close 80.59
    Today's Range 80.42 - 82.39
    52wk Range 44.27 - 84.15
    Shares Outstanding 22,263,235
    Dividend Yield 0.69%
    Chart for (: )
    Intraday 1 Week 1 Month 3 Month 1 Year 3 Year 5 Year

    Top News

    More News
    Navigating 4 Analyst Ratings For LeMaitre Vascular
    Via Benzinga
    Stryker Stock Sees RS Rating Treks Higher To 71
    Stryker stock saw a positive improvement to its Relative Strength (RS) Rating on Wednesday, with an increase from 63 to 71. 
    Via Investor's Business Daily

    Performance

    YTD
    +43.71%
    +43.71%
    1 Month
    +1.85%
    +1.85%
    3 Month
    +22.67%
    +22.67%
    6 Month
    +43.16%
    +43.16%
    1 Year
    +19.84%
    +19.84%

    More News

    Read More
    Sell In May And Go Away? – April Dividend Income Report
    Via Talk Markets
    LMAT Stock Earnings: LeMaitre Vascular Beats EPS, Beats Revenue for Q1 2024
    Via InvestorPlace
    Inspire Medical Systems Stock Sees IBD RS Rating Rise To 78
    Via Investor's Business Daily
    Barrington Research Maintains Outperform Rating for LeMaitre Vascular: Here's What You Need To Know
    Via Benzinga
    Recap: LeMaitre Vascular Q4 Earnings
    Via Benzinga
    Earnings Scheduled For February 27, 2024
    Via Benzinga
    A Preview Of LeMaitre Vascular's Earnings
    Via Benzinga
    5 Analysts Have This to Say About LeMaitre Vascular
    Via Benzinga
    Sidoti Events, LLC's Virtual December Small-Cap Conference
    Via ACCESSWIRE
    Why LeMaitre Vascular Is A Market Leader In Core Segments: Oppenheimer Initiates With Outperform Rating
    Via Benzinga
    Looking for Dividend Growth? Buy This Little-Known Healthcare Stock
    Via The Motley Fool
    2 Healthcare Stocks That Could Help Make You a Fortune
    Via The Motley Fool
    Boston Scientific Stock Gets 81 RS Rating After Profit Pops 56% In Year
    Via Investor's Business Daily
    Recap: LeMaitre Vascular Q1 Earnings
    Via Benzinga
    Benzinga's Top Ratings Upgrades, Downgrades For September 6, 2023
    Via Benzinga
    Benzinga's Top Ratings Upgrades, Downgrades For August 3, 2023
    Via Benzinga
    Yum! Brands To Rally Around 20%? Here Are 10 Other Analyst Forecasts For Thursday
    Via Benzinga
    3 Micro-Cap Stocks to Buy Now for Gigantic Growth Potential
    Via InvestorPlace
    Beat the Dow Jones With This Unstoppable Dividend Stock
    Via The Motley Fool
    Sidoti Events, LLC's Virtual June Small-Cap Conference
    Via ACCESSWIRE
    Is This Healthcare Stock a Buy for Dividend Growth Investors?
    Via The Motley Fool
    Why Shares of LeMaitre Vascular Are Up Wednesday
    Via The Motley Fool
    Benzinga's Top Ratings Upgrades, Downgrades For May 3, 2023
    Via Benzinga
    Data & News supplied by www.cloudquote.io
    Stock quotes supplied by Barchart
    Quotes delayed at least 20 minutes.
    By accessing this page, you agree to the following
    Privacy Policy and Terms and Conditions.